Organovo Holdings, Inc. (NYSEMKT:ONVO)

CAPS Rating: 2 out of 5

Recs

1
Player Avatar terrell1951 (< 20) Submitted: 1/22/2013 2:55:53 PM : Outperform Start Price: $5.43 ONVO Score: -13.61

Already having success on the cellular level and the Supreme Court ruling in favor of Stem Cell research, I believe this company is a good bet for the future. With organizations like Pfizer, Harvard Medical School, United Therapeutics Corp, Columbia University's Laboratory for Stem Cell and Tissue Engineering, among other medical schools already using this technology, I can't wait to see what the future will bring for advancement in medicine for the human body, and maybe one day, taking a drug with "no side effects"!! I got into this stock in Dec 2012 @ $2.15. It will take time, I'm in for the long term!

Featured Broker Partners


Advertisement